Enhancement of Physical Activity in Elderly Patients With Diastolic Heart Failure by a Motivational Intervention
NCT ID: NCT03402490
Last Updated: 2018-01-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
39 participants
INTERVENTIONAL
2013-06-18
2015-12-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Effects of Preferred Home-based Exercise Training in Systolic Heart Failure
NCT02051712
Activity Level and Barriers to Participate of Cardiac Rehabilitation in Advanced Heart Failure Patients
NCT03385837
Motivational Program on Physical Activity in Cardio-respiratory Patients: an RCT Study
NCT05318482
Effect of Exercise-based Rehabilitation on Circulatory Functions in Patients With Diastolic Heart Failure
NCT01053091
Interventions to Improve Daily Activity in Heart Failure
NCT02331524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the first two and the last sessions participants met with the psychologist-counsellor face-to-face for about 45 minutes. The remaining three sessions could be conducted via telephone or face-to-face, depending on participants' preferences, and typically lasted 15-30 minutes. Per study protocol, counsellors (physicians and psychologists trained in motivational interviewing) assisted the participants in: (1) Setting goals for their physical activity; (2) developing a plan to increase physical activities; (3) setting specific plans for the implementation of the plan; and (4) overcoming possible barriers. Participants were also asked to keep track of their daily physical activity in a diary, which counsellors then discussed with them during the sessions.
After patients had given their written informed consent, counsellors assessed all participants via structured interview and self-rating scales. At baseline only, sociodemographic information was recorded.
At baseline and at the final 6-month visit participants' motivation to be physically active in the upcoming weeks was assessed using the SSK-scale ("Sportbezogene Selbstkonkord" = sports-related self-concordance, Seelig and Fuchs 2006) to assess the self concordance of sport- and exercise-related goals.
The kind and extent of patients' daily physical activity was recorded using patient diaries. At baseline and 6 months we also conducted a symptom-limited cardiopulmonary exercise test on a bicycle ergometer, in order to assess changes in maximum rate of oxygen consumption during the last 30 seconds before the termination of the exercise (peak oxygen consumption (VO2 \[ml/min/kg\])) as measure of maximal exercise capacity. Participants also completed the 6-minute walk test on flat surface (6-MWT) as an additional parameter to assess submaximal exercise capacity.
Additionally, at the 6-month assessment, intervention participants filled out a questionnaire about their subjective evaluation of the counseling program.
The control group (n=20) received usual care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Motivational interviewing
Over a time span of 6 months, participants in the intervention group received up to 7 sessions of motivational counseling, lasting 15-30 minutes each, to enhance physical activity.
Motivational interviewing
Usual care
Participants who served as controls received usual care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motivational interviewing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* echocardiographically determined diastolic dysfunction (grade ≥ 1),
* New York Heart association functional classes I, II or III,
* at least one cardiovascular risk-factor (overweight, diabetes, hypertension, smoking or hyperlipidemia)
* participation in Ex-DHF main study
* written informed consent
Exclusion Criteria
* Chronic obstructive pulmonary disease GOLD stages ≥II
* Anaemia (haemoglobin \<11 mg/dL)
* Significant renal dysfunction (eGFR \<30 mL/min/1.73 m\*\*2 indexed to BSA)
* Significant peripheral artery disease (Fontaine ≥IIb)
* Musculoskeletal disease that contributes to reduced exercise performance
* Specific cardiomyopathy (e.g. amyloidosis)
* Haemodynamically significant valvular disorders
* Significant coronary artery disease (current angina pectoris Canadian Cardiovascular Society Class ≥II or positive stress test, myocardial infarction or coronary artery bypass graft within the last 3 months)
* Any inability or contraindication to participate in cardiopulmonary exercise testing or in an exercise programme (e.g. physiological, mental) or to supply essential information (e.g. questionnaire, diary)
* Ineffective control of resting blood pressure (≥140/90 mmHg or ≥160/100 mmHg with ≥3 antihypertensive drugs) or of resting heart rate (≥100 b.p.m.)
* Expected low adherence (e.g. by travel distance to trial site; planned absences longer than 4 weeks during follow-up) or ongoing drug abuse
* Pregnant or nursing women
* Concomitant participation in other interventional clinical trials
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
OTHER
University of Göttingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christoph Herrmann-Lingen
Prof. Dr.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12345 add-on
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.